Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the american academy of neurology.
Mauskop
Alexander
A
Mathew
Ninan
N
D001342:Autonomic Nervous System Diseases / Q000188:drug therapy*; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D015201:Meta-Analysis as Topic; D008881:Migraine Disorders / Q000188:drug therapy; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy*; D018781:Tension-Type Headache / Q000188:drug therapy
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A